We are live on ! Find out more
NPT

Nixon Peabody Trust Portfolio holdings

AUM $1.41B
1-Year Est. Return 27.78%
This Fund
S&P 500
This Quarter Est. Return
+1.72%
1 Year Est. Return
+27.78%
3 Year Est. Return
+85.33%
5 Year Est. Return
+107.3%
10 Year Est. Return
+380.86%
AUM
$1.21B
AUM Growth
+$13.1M
Cap. Flow
+$8.6M
Cap. Flow %
0.71%
Top 10 Hldgs %
43.73%
Holding
152
New
13
Increased
73
Reduced
40
Closed
5

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$7.37M
2
LLY icon
Eli Lilly
LLY
+$6.73M
3
NOW icon
ServiceNow
NOW
+$6.52M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.42M
5
VRT icon
Vertiv
VRT
+$5.2M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$8.45M
2
ROP icon
Roper Technologies
ROP
+$8.39M
3
ROK icon
Rockwell Automation
ROK
+$7.79M
4
MDT icon
Medtronic
MDT
+$6.89M
5
CMCSA icon
Comcast
CMCSA
+$6.88M

Sector Composition

Rank Sector Weight
1 Technology 24.02%
2 Financials 10.78%
3 Industrials 9.93%
4 Healthcare 9.42%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRE icon
151
Sempra
SRE
$57.9B
– –
-2,492
Closed -$208K
UL icon
152
Unilever
UL
$137B
– –
-3,122
Closed -$228K
3 4 5 6
7

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return

Nixon Peabody Trust's Q4 2024 Portfolio in Review

As of Q4 2024, Nixon Peabody Trust held 152 positions worth $1.21B, up 1.1% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Nixon Peabody Trust's Q4 2024 filing shows 13 new, 73 increased, 40 reduced and 5 closed positions. Its largest new stake was ASML: 10,257 shares worth $7.11M. The largest sale was Novartis, an estimated $8.45M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.

  • Nixon Peabody Trust's largest Q4 2024 buy was ASML: 10,257 shares worth $7.11M.
  • Nixon Peabody Trust added most to Eli Lilly in Q4 2024, an estimated $6.73M increase.
  • Nixon Peabody Trust's biggest Q4 2024 reduction was Novartis, cutting an estimated $8.45M.
  • Nixon Peabody Trust fully exited A.O. Smith in Q4 2024, selling an estimated $262K.
  • Nixon Peabody Trust's ten largest holdings make up 44% of its $1.21B portfolio in Q4 2024.
  • Nixon Peabody Trust opened 13 new positions and closed 5 in Q4 2024.
  • Nixon Peabody Trust's portfolio value rose 1.1% quarter-over-quarter to $1.21B.

Based on Nixon Peabody Trust's 13F filing for Q4 2024, filed 5 Feb 2025.